

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.96788935 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.69562720 |
| 3 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.02566791 |
| 4 | histone H3-K36 demethylation (GO:0070544) | 3.80564314 |
| 5 | positive regulation of granulocyte differentiation (GO:0030854) | 3.73526081 |
| 6 | definitive hemopoiesis (GO:0060216) | 3.70556092 |
| 7 | histone H3-K9 modification (GO:0061647) | 3.55658798 |
| 8 | nuclear pore complex assembly (GO:0051292) | 3.50045214 |
| 9 | mitotic sister chromatid cohesion (GO:0007064) | 3.49372416 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.46560807 |
| 11 | histone H3-K9 methylation (GO:0051567) | 3.46305573 |
| 12 | positive T cell selection (GO:0043368) | 3.45211976 |
| 13 | DNA unwinding involved in DNA replication (GO:0006268) | 3.37215385 |
| 14 | regulation of DNA endoreduplication (GO:0032875) | 3.31429624 |
| 15 | regulation of histone H3-K27 methylation (GO:0061085) | 3.31063067 |
| 16 | mitotic chromosome condensation (GO:0007076) | 3.30900772 |
| 17 | nuclear pore organization (GO:0006999) | 3.09675057 |
| 18 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.07123213 |
| 19 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.07123213 |
| 20 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.07123213 |
| 21 | interkinetic nuclear migration (GO:0022027) | 3.05524600 |
| 22 | T cell selection (GO:0045058) | 3.05434220 |
| 23 | positive thymic T cell selection (GO:0045059) | 3.01987144 |
| 24 | histone lysine demethylation (GO:0070076) | 2.99841292 |
| 25 | histone demethylation (GO:0016577) | 2.93523673 |
| 26 | peptidyl-lysine methylation (GO:0018022) | 2.90756459 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88128376 |
| 28 | negative regulation of cell killing (GO:0031342) | 2.88128376 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 2.86274484 |
| 30 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.83897399 |
| 31 | germ cell migration (GO:0008354) | 2.81278534 |
| 32 | T cell migration (GO:0072678) | 2.79531206 |
| 33 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.78656601 |
| 34 | regulation of histone methylation (GO:0031060) | 2.77675776 |
| 35 | thymic T cell selection (GO:0045061) | 2.77540759 |
| 36 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.76917911 |
| 37 | negative regulation of B cell proliferation (GO:0030889) | 2.76317216 |
| 38 | histone lysine methylation (GO:0034968) | 2.76182875 |
| 39 | histone H3-K9 demethylation (GO:0033169) | 2.73432921 |
| 40 | dosage compensation (GO:0007549) | 2.72747350 |
| 41 | N-terminal protein amino acid acetylation (GO:0006474) | 2.72737184 |
| 42 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.70231612 |
| 43 | regulation of RNA export from nucleus (GO:0046831) | 2.69809950 |
| 44 | V(D)J recombination (GO:0033151) | 2.67056305 |
| 45 | histone-serine phosphorylation (GO:0035404) | 2.66987601 |
| 46 | pore complex assembly (GO:0046931) | 2.66286902 |
| 47 | B cell proliferation (GO:0042100) | 2.66281636 |
| 48 | regulation of DNA methylation (GO:0044030) | 2.65643236 |
| 49 | B cell homeostasis (GO:0001782) | 2.65374429 |
| 50 | positive regulation of histone methylation (GO:0031062) | 2.62645639 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.62332165 |
| 52 | interferon-gamma production (GO:0032609) | 2.61612620 |
| 53 | histone H3-K4 trimethylation (GO:0080182) | 2.60492349 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59622205 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58242829 |
| 56 | DNA topological change (GO:0006265) | 2.57936854 |
| 57 | response to muramyl dipeptide (GO:0032495) | 2.57543828 |
| 58 | sister chromatid cohesion (GO:0007062) | 2.56589786 |
| 59 | regulation of gamma-delta T cell activation (GO:0046643) | 2.53970068 |
| 60 | hypotonic response (GO:0006971) | 2.52285893 |
| 61 | protein dealkylation (GO:0008214) | 2.51797828 |
| 62 | protein demethylation (GO:0006482) | 2.51797828 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.50739032 |
| 64 | histone mRNA catabolic process (GO:0071044) | 2.48252899 |
| 65 | regulation of fibroblast apoptotic process (GO:2000269) | 2.45081754 |
| 66 | tolerance induction (GO:0002507) | 2.44557657 |
| 67 | DNA geometric change (GO:0032392) | 2.43437549 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.42905893 |
| 69 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.42124282 |
| 70 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.41777559 |
| 71 | DNA duplex unwinding (GO:0032508) | 2.41691372 |
| 72 | regulation of B cell differentiation (GO:0045577) | 2.39284549 |
| 73 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.38520437 |
| 74 | regulation of thymocyte apoptotic process (GO:0070243) | 2.37971801 |
| 75 | regulation of granulocyte differentiation (GO:0030852) | 2.37096985 |
| 76 | negative regulation of histone modification (GO:0031057) | 2.36013493 |
| 77 | nucleus organization (GO:0006997) | 2.35101843 |
| 78 | regulation of histone H3-K4 methylation (GO:0051569) | 2.34944531 |
| 79 | T cell homeostasis (GO:0043029) | 2.34675168 |
| 80 | peptidyl-lysine trimethylation (GO:0018023) | 2.33818296 |
| 81 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.33365472 |
| 82 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.33297192 |
| 83 | negative regulation of DNA repair (GO:0045738) | 2.31263450 |
| 84 | embryonic process involved in female pregnancy (GO:0060136) | 2.31210014 |
| 85 | cellular extravasation (GO:0045123) | 2.31096355 |
| 86 | regulation of sister chromatid cohesion (GO:0007063) | 2.30843824 |
| 87 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.30495355 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.30312651 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 2.30312651 |
| 90 | positive regulation by symbiont of host defense response (GO:0052509) | 2.30312651 |
| 91 | modulation by symbiont of host defense response (GO:0052031) | 2.30312651 |
| 92 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.30312651 |
| 93 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.30312651 |
| 94 | cellular response to ethanol (GO:0071361) | 2.29865311 |
| 95 | DNA synthesis involved in DNA repair (GO:0000731) | 2.29610824 |
| 96 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.29543234 |
| 97 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.29427031 |
| 98 | positive regulation of developmental pigmentation (GO:0048087) | 2.28959731 |
| 99 | peptidyl-lysine dimethylation (GO:0018027) | 2.28913238 |
| 100 | histone H4-K16 acetylation (GO:0043984) | 2.28718672 |
| 101 | substrate-dependent cell migration (GO:0006929) | 2.27840884 |
| 102 | SMAD protein complex assembly (GO:0007183) | 2.27689375 |
| 103 | negative regulation of histone methylation (GO:0031061) | 2.26958986 |
| 104 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.26826869 |
| 105 | negative regulation of RNA splicing (GO:0033119) | 2.26520610 |
| 106 | histone deubiquitination (GO:0016578) | 2.26032442 |
| 107 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.25456571 |
| 108 | kinetochore organization (GO:0051383) | 2.25135365 |
| 109 | histone H3-K4 methylation (GO:0051568) | 2.24555493 |
| 110 | peptidyl-threonine phosphorylation (GO:0018107) | 2.24453332 |
| 111 | negative regulation of T cell mediated immunity (GO:0002710) | 2.23567083 |
| 112 | lymphocyte homeostasis (GO:0002260) | 2.23203692 |
| 113 | translesion synthesis (GO:0019985) | 2.22363715 |
| 114 | negative regulation of chromatin modification (GO:1903309) | 2.22352460 |
| 115 | regulation of histone H3-K9 methylation (GO:0051570) | 2.21965251 |
| 116 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.21583980 |
| 117 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.21583980 |
| 118 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.21583980 |
| 119 | neural tube formation (GO:0001841) | 2.20913127 |
| 120 | embryonic hemopoiesis (GO:0035162) | 2.19081594 |
| 121 | positive regulation of defense response to virus by host (GO:0002230) | 2.18635767 |
| 122 | response to interleukin-15 (GO:0070672) | 2.18613756 |
| 123 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.17754036 |
| 124 | necroptotic process (GO:0070266) | 2.16862440 |
| 125 | mRNA stabilization (GO:0048255) | 2.16825596 |
| 126 | RNA stabilization (GO:0043489) | 2.16825596 |
| 127 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.15743875 |
| 128 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.14704310 |
| 129 | neutrophil activation involved in immune response (GO:0002283) | 2.12660819 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.12460779 |
| 131 | ribosomal small subunit assembly (GO:0000028) | 2.10812370 |
| 132 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.10350872 |
| 133 | hepatocyte apoptotic process (GO:0097284) | 2.09672073 |
| 134 | chromatin assembly (GO:0031497) | 2.09650690 |
| 135 | negative regulation of bone resorption (GO:0045779) | 2.08730194 |
| 136 | regulation of stem cell maintenance (GO:2000036) | 2.08699868 |
| 137 | erythrocyte maturation (GO:0043249) | 2.07393059 |
| 138 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.07216209 |
| 139 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.07216209 |
| 140 | negative regulation of bone remodeling (GO:0046851) | 2.06146936 |
| 141 | negative regulation of granulocyte differentiation (GO:0030853) | 2.04028009 |
| 142 | DNA strand renaturation (GO:0000733) | 2.03073146 |
| 143 | pre-miRNA processing (GO:0031054) | 2.02881264 |
| 144 | positive regulation of interferon-alpha production (GO:0032727) | 2.02802691 |
| 145 | regulation of chromatin silencing (GO:0031935) | 2.02328166 |
| 146 | negative regulation of phagocytosis (GO:0050765) | 2.02214544 |
| 147 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.01532160 |
| 148 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.01374435 |
| 149 | T-helper cell differentiation (GO:0042093) | 2.01374435 |
| 150 | I-kappaB phosphorylation (GO:0007252) | 2.01107243 |
| 151 | T cell differentiation in thymus (GO:0033077) | 2.00848634 |
| 152 | mRNA splice site selection (GO:0006376) | 2.00631169 |
| 153 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.00228470 |
| 154 | mitotic recombination (GO:0006312) | 1.99764521 |
| 155 | alpha-beta T cell activation (GO:0046631) | 1.99729649 |
| 156 | negative T cell selection (GO:0043383) | 1.99359137 |
| 157 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 1.98791580 |
| 158 | sister chromatid segregation (GO:0000819) | 1.98694408 |
| 159 | T cell differentiation (GO:0030217) | 1.96999472 |
| 160 | negative thymic T cell selection (GO:0045060) | 1.96791180 |
| 161 | necrotic cell death (GO:0070265) | 1.96367378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.25838636 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.87891790 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.54200693 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.69933465 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.64134150 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.61700874 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.48540171 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.33001681 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.10500917 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.97317048 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.86383511 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81274413 |
| 13 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.59805335 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.48109481 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47395564 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.24836544 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20628192 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.18579613 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14800777 |
| 20 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.08512031 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08431003 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07475860 |
| 23 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.06127655 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.05889476 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04257344 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02659714 |
| 27 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.86929899 |
| 28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.83817399 |
| 29 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83519745 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82621290 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81426401 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.78621573 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75823767 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73451699 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.72447519 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71134826 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67135923 |
| 38 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.64092153 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58570773 |
| 40 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.55373496 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54532608 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54181128 |
| 43 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51393723 |
| 44 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.49647895 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.49335872 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.48171442 |
| 47 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45604036 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41097938 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.39339470 |
| 50 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.36198514 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.34597358 |
| 52 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.32762545 |
| 53 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32647924 |
| 54 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32426748 |
| 55 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.31232079 |
| 56 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.29922467 |
| 57 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.29319050 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26216916 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25885912 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.25135817 |
| 61 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21455390 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21079386 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19290714 |
| 64 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14977053 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14555010 |
| 66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13253832 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12253046 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12200093 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11609737 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10180663 |
| 71 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08456693 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07684675 |
| 73 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.07588063 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07141089 |
| 75 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.05421217 |
| 76 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.05421217 |
| 77 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.05421217 |
| 78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03476340 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03476340 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01818069 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01731460 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00714540 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00543213 |
| 84 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00120133 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99268654 |
| 86 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98858565 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98104608 |
| 88 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.97766647 |
| 89 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97462753 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97041940 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95211305 |
| 92 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94925759 |
| 93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94163581 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93453466 |
| 95 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.92219596 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91920036 |
| 97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91444473 |
| 98 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91267370 |
| 99 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90464908 |
| 100 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90433674 |
| 101 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90141719 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89746255 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89200490 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88887053 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88347237 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88202323 |
| 107 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.87305986 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84896221 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 0.84849838 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84374708 |
| 111 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84013036 |
| 112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83874528 |
| 113 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83280928 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83180091 |
| 115 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.82150825 |
| 116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.81890322 |
| 117 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.80522439 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80409235 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79991516 |
| 120 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.79561969 |
| 121 | FUS_26573619_Chip-Seq_HEK293_Human | 0.78818753 |
| 122 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.77720021 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76455050 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76033532 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.74522054 |
| 126 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.73752066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.69367032 |
| 2 | MP0008057_abnormal_DNA_replication | 2.63996306 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.38151265 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.35715027 |
| 5 | MP0004808_abnormal_hematopoietic_stem | 2.27491840 |
| 6 | MP0008007_abnormal_cellular_replicative | 2.05605886 |
| 7 | MP0002166_altered_tumor_susceptibility | 1.94663737 |
| 8 | MP0005174_abnormal_tail_pigmentation | 1.91440076 |
| 9 | MP0010094_abnormal_chromosome_stability | 1.87418073 |
| 10 | MP0003300_gastrointestinal_ulcer | 1.81067307 |
| 11 | MP0001800_abnormal_humoral_immune | 1.80693865 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 1.76980829 |
| 13 | MP0001879_abnormal_lymphatic_vessel | 1.75886101 |
| 14 | MP0002006_tumorigenesis | 1.71152466 |
| 15 | MP0002452_abnormal_antigen_presenting | 1.70481088 |
| 16 | MP0003121_genomic_imprinting | 1.70131703 |
| 17 | MP0000685_abnormal_immune_system | 1.67912511 |
| 18 | MP0008877_abnormal_DNA_methylation | 1.64711271 |
| 19 | MP0010307_abnormal_tumor_latency | 1.62461741 |
| 20 | MP0002938_white_spotting | 1.61675810 |
| 21 | MP0002398_abnormal_bone_marrow | 1.59117342 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.57623796 |
| 23 | MP0005076_abnormal_cell_differentiation | 1.55525256 |
| 24 | MP0005671_abnormal_response_to | 1.55458648 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.53660167 |
| 26 | MP0002723_abnormal_immune_serum | 1.52326569 |
| 27 | MP0006054_spinal_hemorrhage | 1.51312472 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.51198316 |
| 29 | MP0001790_abnormal_immune_system | 1.50522735 |
| 30 | MP0005387_immune_system_phenotype | 1.50522735 |
| 31 | MP0001819_abnormal_immune_cell | 1.48674877 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.48616352 |
| 33 | MP0009278_abnormal_bone_marrow | 1.47779765 |
| 34 | MP0002009_preneoplasia | 1.47626465 |
| 35 | MP0003077_abnormal_cell_cycle | 1.40889289 |
| 36 | MP0008058_abnormal_DNA_repair | 1.39984224 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.39469743 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.39322403 |
| 39 | MP0002419_abnormal_innate_immunity | 1.38161375 |
| 40 | MP0009785_altered_susceptibility_to | 1.36903572 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.35442947 |
| 42 | MP0003787_abnormal_imprinting | 1.34273295 |
| 43 | MP0008260_abnormal_autophagy | 1.31895381 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.31218360 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.31218360 |
| 46 | MP0009697_abnormal_copulation | 1.29949443 |
| 47 | MP0002405_respiratory_system_inflammati | 1.29551028 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.28460217 |
| 49 | MP0002722_abnormal_immune_system | 1.27869001 |
| 50 | MP0000716_abnormal_immune_system | 1.27088202 |
| 51 | MP0003122_maternal_imprinting | 1.26848885 |
| 52 | MP0003436_decreased_susceptibility_to | 1.25150290 |
| 53 | MP0005621_abnormal_cell_physiology | 1.24483512 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.23895904 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.23237508 |
| 56 | MP0001293_anophthalmia | 1.21675903 |
| 57 | MP0001851_eye_inflammation | 1.21293450 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.20692536 |
| 59 | MP0003111_abnormal_nucleus_morphology | 1.20288219 |
| 60 | MP0005025_abnormal_response_to | 1.19258812 |
| 61 | MP0000490_abnormal_crypts_of | 1.15883186 |
| 62 | MP0002933_joint_inflammation | 1.14388001 |
| 63 | MP0003868_abnormal_feces_composition | 1.14312062 |
| 64 | MP0003984_embryonic_growth_retardation | 1.13983291 |
| 65 | MP0003693_abnormal_embryo_hatching | 1.13950743 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.13927265 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.13679196 |
| 68 | MP0000428_abnormal_craniofacial_morphol | 1.12351209 |
| 69 | MP0002429_abnormal_blood_cell | 1.12239471 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.11397930 |
| 71 | MP0003890_abnormal_embryonic-extraembry | 1.11284373 |
| 72 | MP0004957_abnormal_blastocyst_morpholog | 1.10003932 |
| 73 | MP0003724_increased_susceptibility_to | 1.09738582 |
| 74 | MP0002088_abnormal_embryonic_growth/wei | 1.09570064 |
| 75 | MP0003943_abnormal_hepatobiliary_system | 1.09432982 |
| 76 | MP0010368_abnormal_lymphatic_system | 1.08667293 |
| 77 | MP0005380_embryogenesis_phenotype | 1.07853513 |
| 78 | MP0001672_abnormal_embryogenesis/_devel | 1.07853513 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.07140072 |
| 80 | MP0005409_darkened_coat_color | 1.05257487 |
| 81 | MP0001915_intracranial_hemorrhage | 1.03948300 |
| 82 | MP0002928_abnormal_bile_duct | 1.02992190 |
| 83 | MP0001730_embryonic_growth_arrest | 1.02563509 |
| 84 | MP0002092_abnormal_eye_morphology | 1.01366727 |
| 85 | MP0004197_abnormal_fetal_growth/weight/ | 1.01097010 |
| 86 | MP0003303_peritoneal_inflammation | 1.00789720 |
| 87 | MP0002086_abnormal_extraembryonic_tissu | 0.99050684 |
| 88 | MP0005310_abnormal_salivary_gland | 0.98041402 |
| 89 | MP0003828_pulmonary_edema | 0.97774844 |
| 90 | MP0000537_abnormal_urethra_morphology | 0.97153772 |
| 91 | MP0003448_altered_tumor_morphology | 0.96622116 |
| 92 | MP0001853_heart_inflammation | 0.96569091 |
| 93 | MP0004947_skin_inflammation | 0.96430831 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.96104336 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.94884115 |
| 96 | MP0000858_altered_metastatic_potential | 0.93287108 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.92391614 |
| 98 | MP0002925_abnormal_cardiovascular_devel | 0.92323551 |
| 99 | MP0003045_fibrosis | 0.91666928 |
| 100 | MP0000350_abnormal_cell_proliferation | 0.91095802 |
| 101 | MP0001873_stomach_inflammation | 0.90349484 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.90030549 |
| 103 | MP0000516_abnormal_urinary_system | 0.89998940 |
| 104 | MP0005367_renal/urinary_system_phenotyp | 0.89998940 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89918016 |
| 106 | MP0005503_abnormal_tendon_morphology | 0.89681585 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.89152418 |
| 108 | MP0003091_abnormal_cell_migration | 0.88812933 |
| 109 | MP0000733_abnormal_muscle_development | 0.87183044 |
| 110 | MP0009703_decreased_birth_body | 0.84457219 |
| 111 | MP0000313_abnormal_cell_death | 0.84010850 |
| 112 | MP0003935_abnormal_craniofacial_develop | 0.83182895 |
| 113 | MP0002177_abnormal_outer_ear | 0.82628032 |
| 114 | MP0003279_aneurysm | 0.82522305 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.82097315 |
| 116 | MP0001697_abnormal_embryo_size | 0.81495958 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.81423963 |
| 118 | MP0010678_abnormal_skin_adnexa | 0.81219092 |
| 119 | MP0002697_abnormal_eye_size | 0.80997313 |
| 120 | MP0001188_hyperpigmentation | 0.80882304 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.80765595 |
| 122 | MP0005384_cellular_phenotype | 0.80238808 |
| 123 | MP0002019_abnormal_tumor_incidence | 0.79947687 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.79753614 |
| 125 | MP0001784_abnormal_fluid_regulation | 0.79588650 |
| 126 | MP0000767_abnormal_smooth_muscle | 0.79141336 |
| 127 | MP0004381_abnormal_hair_follicle | 0.75121526 |
| 128 | MP0004134_abnormal_chest_morphology | 0.74928759 |
| 129 | MP0002168_other_aberrant_phenotype | 0.73764933 |
| 130 | MP0002084_abnormal_developmental_patter | 0.73353698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Syringomyelia (HP:0003396) | 3.31209712 |
| 2 | Spinal cord lesions (HP:0100561) | 3.31209712 |
| 3 | Abnormality of the fingertips (HP:0001211) | 3.22554173 |
| 4 | Heterotopia (HP:0002282) | 3.18683980 |
| 5 | Subacute progressive viral hepatitis (HP:0006572) | 2.93579700 |
| 6 | Volvulus (HP:0002580) | 2.88921074 |
| 7 | Optic neuritis (HP:0100653) | 2.79206963 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 2.79206963 |
| 9 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.76239794 |
| 10 | Short 4th metacarpal (HP:0010044) | 2.76239794 |
| 11 | Increased density of long bones (HP:0006392) | 2.72502941 |
| 12 | Colitis (HP:0002583) | 2.66660595 |
| 13 | Myositis (HP:0100614) | 2.64169401 |
| 14 | Papillary thyroid carcinoma (HP:0002895) | 2.59977394 |
| 15 | Acute myeloid leukemia (HP:0004808) | 2.56672037 |
| 16 | Spontaneous hematomas (HP:0007420) | 2.54435908 |
| 17 | Orchitis (HP:0100796) | 2.49951488 |
| 18 | Basal cell carcinoma (HP:0002671) | 2.42710144 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37614013 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37614013 |
| 21 | Acute lymphatic leukemia (HP:0006721) | 2.32073888 |
| 22 | Absent frontal sinuses (HP:0002688) | 2.31732070 |
| 23 | Inflammation of the large intestine (HP:0002037) | 2.31070236 |
| 24 | Hematochezia (HP:0002573) | 2.30939906 |
| 25 | Conjunctival telangiectasia (HP:0000524) | 2.27338398 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 2.26944023 |
| 27 | Persistence of primary teeth (HP:0006335) | 2.25219804 |
| 28 | Viral hepatitis (HP:0006562) | 2.22604217 |
| 29 | Sandal gap (HP:0001852) | 2.21785059 |
| 30 | Arterial thrombosis (HP:0004420) | 2.20365853 |
| 31 | Deep palmar crease (HP:0006191) | 2.19752585 |
| 32 | Recurrent viral infections (HP:0004429) | 2.15885665 |
| 33 | Deep philtrum (HP:0002002) | 2.14902928 |
| 34 | Periodontitis (HP:0000704) | 2.14896114 |
| 35 | Facial hemangioma (HP:0000329) | 2.12785860 |
| 36 | Chromsome breakage (HP:0040012) | 2.10334199 |
| 37 | Hypoplasia of the thymus (HP:0000778) | 2.08378014 |
| 38 | Abnormality of the nasal septum (HP:0000419) | 2.08132946 |
| 39 | Thyroiditis (HP:0100646) | 2.07838386 |
| 40 | IgM deficiency (HP:0002850) | 2.06959358 |
| 41 | Narrow palate (HP:0000189) | 2.02763284 |
| 42 | Thrombocytosis (HP:0001894) | 2.01369285 |
| 43 | Abnormal foot bone ossification (HP:0010675) | 2.00769539 |
| 44 | Long eyelashes (HP:0000527) | 2.00711493 |
| 45 | Asymmetry of the thorax (HP:0001555) | 2.00599738 |
| 46 | Lymphopenia (HP:0001888) | 1.99663345 |
| 47 | Severe combined immunodeficiency (HP:0004430) | 1.97718805 |
| 48 | Relative macrocephaly (HP:0004482) | 1.97519320 |
| 49 | Cystic hygroma (HP:0000476) | 1.97278387 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 1.96595638 |
| 51 | B lymphocytopenia (HP:0010976) | 1.93693640 |
| 52 | Gastrointestinal stroma tumor (HP:0100723) | 1.91118093 |
| 53 | T lymphocytopenia (HP:0005403) | 1.90725265 |
| 54 | Skull defect (HP:0001362) | 1.89952944 |
| 55 | IgA deficiency (HP:0002720) | 1.89310614 |
| 56 | Abnormality of B cell number (HP:0010975) | 1.89270549 |
| 57 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88957799 |
| 58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88491685 |
| 59 | Cutis marmorata (HP:0000965) | 1.88166406 |
| 60 | Combined immunodeficiency (HP:0005387) | 1.87631026 |
| 61 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.87027008 |
| 62 | Spondylolisthesis (HP:0003302) | 1.86691590 |
| 63 | Smooth philtrum (HP:0000319) | 1.86685028 |
| 64 | Ankyloglossia (HP:0010296) | 1.85612658 |
| 65 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.84699732 |
| 66 | Granulocytopenia (HP:0001913) | 1.84622984 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 1.84382858 |
| 68 | Ectopic kidney (HP:0000086) | 1.84343078 |
| 69 | Overgrowth (HP:0001548) | 1.83346246 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81795780 |
| 71 | 11 pairs of ribs (HP:0000878) | 1.81572634 |
| 72 | Abnormality of oral frenula (HP:0000190) | 1.81493048 |
| 73 | Abnormality of T cell number (HP:0011839) | 1.81269318 |
| 74 | Abnormality of DNA repair (HP:0003254) | 1.81228724 |
| 75 | Chronic hepatic failure (HP:0100626) | 1.80645851 |
| 76 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.80130332 |
| 77 | Neoplasm of the oral cavity (HP:0100649) | 1.78993924 |
| 78 | Aortic aneurysm (HP:0004942) | 1.78236030 |
| 79 | Hypoplastic iliac wings (HP:0002866) | 1.78200754 |
| 80 | Eosinophilia (HP:0001880) | 1.78015825 |
| 81 | Midline defect of the nose (HP:0004122) | 1.77252303 |
| 82 | Cellulitis (HP:0100658) | 1.76859846 |
| 83 | Chronic diarrhea (HP:0002028) | 1.76509186 |
| 84 | Cafe-au-lait spot (HP:0000957) | 1.76399896 |
| 85 | Osteomyelitis (HP:0002754) | 1.75819301 |
| 86 | Thick eyebrow (HP:0000574) | 1.75256376 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75077149 |
| 88 | Amaurosis fugax (HP:0100576) | 1.74998400 |
| 89 | Prolonged bleeding time (HP:0003010) | 1.73925193 |
| 90 | Abnormal number of incisors (HP:0011064) | 1.73153494 |
| 91 | Prominent nose (HP:0000448) | 1.72793823 |
| 92 | Bicuspid aortic valve (HP:0001647) | 1.71531745 |
| 93 | Recurrent bronchitis (HP:0002837) | 1.71151276 |
| 94 | Broad palm (HP:0001169) | 1.70908422 |
| 95 | Capillary hemangiomas (HP:0005306) | 1.70824639 |
| 96 | Recurrent fungal infections (HP:0002841) | 1.70683948 |
| 97 | Renal duplication (HP:0000075) | 1.69780956 |
| 98 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.68770103 |
| 99 | Low anterior hairline (HP:0000294) | 1.67923353 |
| 100 | Thickened helices (HP:0000391) | 1.67835668 |
| 101 | Myelodysplasia (HP:0002863) | 1.67471651 |
| 102 | Bladder carcinoma (HP:0002862) | 1.66790137 |
| 103 | Bladder neoplasm (HP:0009725) | 1.66790137 |
| 104 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.66353003 |
| 105 | Abnormality of the 4th metacarpal (HP:0010012) | 1.66060018 |
| 106 | Vasculitis (HP:0002633) | 1.66050446 |
| 107 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.64576189 |
| 108 | Mediastinal lymphadenopathy (HP:0100721) | 1.64072267 |
| 109 | Portal hypertension (HP:0001409) | 1.64047398 |
| 110 | High pitched voice (HP:0001620) | 1.63476534 |
| 111 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.63467981 |
| 112 | Verrucae (HP:0200043) | 1.62581821 |
| 113 | Papilloma (HP:0012740) | 1.62581821 |
| 114 | Eczematoid dermatitis (HP:0000976) | 1.62556014 |
| 115 | Obsessive-compulsive behavior (HP:0000722) | 1.62497929 |
| 116 | Abnormality of the peritoneum (HP:0002585) | 1.62451265 |
| 117 | Embryonal renal neoplasm (HP:0011794) | 1.61714702 |
| 118 | Reticulocytopenia (HP:0001896) | 1.61713369 |
| 119 | Medulloblastoma (HP:0002885) | 1.61618015 |
| 120 | Abnormal platelet volume (HP:0011876) | 1.60638093 |
| 121 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.59990488 |
| 122 | Micronodular cirrhosis (HP:0001413) | 1.59917485 |
| 123 | Lymphoma (HP:0002665) | 1.59760247 |
| 124 | Panhypogammaglobulinemia (HP:0003139) | 1.58555220 |
| 125 | Cubitus valgus (HP:0002967) | 1.58547506 |
| 126 | Tapered finger (HP:0001182) | 1.58542207 |
| 127 | Abnormality of the radial head (HP:0003995) | 1.58215379 |
| 128 | Recurrent abscess formation (HP:0002722) | 1.58158609 |
| 129 | Abnormality of T cells (HP:0002843) | 1.57912134 |
| 130 | Keratoconjunctivitis (HP:0001096) | 1.57709377 |
| 131 | Increased nuchal translucency (HP:0010880) | 1.57386535 |
| 132 | Large earlobe (HP:0009748) | 1.57289736 |
| 133 | Meningitis (HP:0001287) | 1.56574155 |
| 134 | Optic nerve coloboma (HP:0000588) | 1.56533063 |
| 135 | Truncal obesity (HP:0001956) | 1.54942057 |
| 136 | Abnormality of the pleura (HP:0002103) | 1.54564588 |
| 137 | Short middle phalanx of the 5th finger (HP:0004220) | 1.54045490 |
| 138 | Mesomelia (HP:0003027) | 1.53997453 |
| 139 | Wide nose (HP:0000445) | 1.53804507 |
| 140 | Abnormality of the hepatic vasculature (HP:0006707) | 1.53720978 |
| 141 | IgG deficiency (HP:0004315) | 1.53272034 |
| 142 | Hyperacusis (HP:0010780) | 1.52090895 |
| 143 | Dislocated radial head (HP:0003083) | 1.51461619 |
| 144 | Shallow orbits (HP:0000586) | 1.50611125 |
| 145 | Abnormality of chromosome stability (HP:0003220) | 1.49789034 |
| 146 | Cerebral aneurysm (HP:0004944) | 1.49209290 |
| 147 | Hepatitis (HP:0012115) | 1.48327307 |
| 148 | Basal ganglia calcification (HP:0002135) | 1.48275926 |
| 149 | Agnosia (HP:0010524) | 1.47977869 |
| 150 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.46837427 |
| 151 | Gastrointestinal carcinoma (HP:0002672) | 1.46837427 |
| 152 | Premature loss of primary teeth (HP:0006323) | 1.46752576 |
| 153 | Prostate neoplasm (HP:0100787) | 1.46491634 |
| 154 | Macroorchidism (HP:0000053) | 1.45827489 |
| 155 | Agammaglobulinemia (HP:0004432) | 1.45237517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 2.68612305 |
| 2 | MAP3K10 | 2.66129819 |
| 3 | CDK12 | 2.63706688 |
| 4 | BRD4 | 2.51509523 |
| 5 | JAK3 | 2.24249038 |
| 6 | MAP3K14 | 2.20787054 |
| 7 | TGFBR1 | 2.16041623 |
| 8 | AKT3 | 2.12283497 |
| 9 | NUAK1 | 2.06997611 |
| 10 | TXK | 2.03874975 |
| 11 | EEF2K | 1.98586956 |
| 12 | LATS1 | 1.73087292 |
| 13 | IRAK3 | 1.72555044 |
| 14 | MAP3K9 | 1.67902647 |
| 15 | EIF2AK3 | 1.66522999 |
| 16 | MKNK1 | 1.65821931 |
| 17 | MAP4K1 | 1.64756449 |
| 18 | CDC7 | 1.61663992 |
| 19 | TEC | 1.53499165 |
| 20 | KIT | 1.53077763 |
| 21 | STK10 | 1.51447313 |
| 22 | PKN2 | 1.50016098 |
| 23 | PTK6 | 1.49932564 |
| 24 | TGFBR2 | 1.46221150 |
| 25 | ITK | 1.44915512 |
| 26 | BTK | 1.44631273 |
| 27 | CHUK | 1.43124867 |
| 28 | FLT3 | 1.41567945 |
| 29 | RPS6KA4 | 1.41031686 |
| 30 | EPHA3 | 1.40640765 |
| 31 | ZAK | 1.40454891 |
| 32 | NEK2 | 1.38155417 |
| 33 | STK3 | 1.37965781 |
| 34 | FGFR3 | 1.35929713 |
| 35 | PASK | 1.32980623 |
| 36 | ATR | 1.30401882 |
| 37 | TAOK3 | 1.28840998 |
| 38 | RAF1 | 1.28157031 |
| 39 | KSR2 | 1.27461506 |
| 40 | IRAK4 | 1.26964460 |
| 41 | ERBB3 | 1.26833994 |
| 42 | CDK6 | 1.25724373 |
| 43 | IKBKB | 1.24866361 |
| 44 | RIPK4 | 1.21564228 |
| 45 | TRPM7 | 1.20909713 |
| 46 | JAK1 | 1.20641176 |
| 47 | FES | 1.20094808 |
| 48 | YES1 | 1.15647688 |
| 49 | WNK1 | 1.12804275 |
| 50 | PIM1 | 1.11366141 |
| 51 | CDK9 | 1.10504515 |
| 52 | RIPK1 | 1.09047975 |
| 53 | STK24 | 1.05166289 |
| 54 | TYK2 | 1.04121189 |
| 55 | ACVR1B | 1.02664137 |
| 56 | MKNK2 | 1.00132434 |
| 57 | RPS6KB2 | 0.99782498 |
| 58 | SRPK1 | 0.98864637 |
| 59 | BLK | 0.98279728 |
| 60 | MAP3K7 | 0.97070071 |
| 61 | IKBKE | 0.95125388 |
| 62 | TSSK6 | 0.95072582 |
| 63 | CSF1R | 0.94362974 |
| 64 | FRK | 0.93210641 |
| 65 | NEK9 | 0.91823238 |
| 66 | PDGFRB | 0.90898178 |
| 67 | PDGFRA | 0.90105564 |
| 68 | STK4 | 0.90058618 |
| 69 | PLK4 | 0.89057891 |
| 70 | BRAF | 0.87998654 |
| 71 | LCK | 0.87005313 |
| 72 | CAMK1D | 0.86198927 |
| 73 | KSR1 | 0.86140639 |
| 74 | TBK1 | 0.85210384 |
| 75 | HCK | 0.84611923 |
| 76 | EIF2AK2 | 0.84074576 |
| 77 | CSK | 0.81825823 |
| 78 | BMPR2 | 0.80578126 |
| 79 | TAF1 | 0.80518199 |
| 80 | MARK3 | 0.78622424 |
| 81 | HIPK2 | 0.78518621 |
| 82 | BMPR1B | 0.76393030 |
| 83 | CLK1 | 0.75335492 |
| 84 | MAPK11 | 0.74573352 |
| 85 | SGK2 | 0.73200438 |
| 86 | SIK1 | 0.72946351 |
| 87 | ATM | 0.72934306 |
| 88 | SYK | 0.72904442 |
| 89 | LYN | 0.72332063 |
| 90 | CAMK1G | 0.71176807 |
| 91 | TTK | 0.70960335 |
| 92 | CDK4 | 0.70220710 |
| 93 | MAPK7 | 0.70095309 |
| 94 | INSRR | 0.68080485 |
| 95 | SIK2 | 0.67851387 |
| 96 | CSNK1A1L | 0.67653624 |
| 97 | DYRK3 | 0.66764708 |
| 98 | BRSK2 | 0.66090583 |
| 99 | TTN | 0.64923980 |
| 100 | RPS6KA5 | 0.64502538 |
| 101 | LRRK2 | 0.64088099 |
| 102 | MAP2K3 | 0.63657316 |
| 103 | ZAP70 | 0.62780075 |
| 104 | MAP3K2 | 0.60197228 |
| 105 | CHEK1 | 0.59349846 |
| 106 | SGK3 | 0.59336535 |
| 107 | AURKB | 0.57834353 |
| 108 | RPS6KB1 | 0.57537625 |
| 109 | TIE1 | 0.57524046 |
| 110 | NLK | 0.56565830 |
| 111 | CAMKK2 | 0.55960555 |
| 112 | SGK223 | 0.55935871 |
| 113 | SGK494 | 0.55935871 |
| 114 | VRK1 | 0.55151114 |
| 115 | GRK6 | 0.54781981 |
| 116 | MELK | 0.52877873 |
| 117 | MTOR | 0.52317527 |
| 118 | CDK3 | 0.52170685 |
| 119 | PNCK | 0.51805630 |
| 120 | MOS | 0.50983513 |
| 121 | CDK7 | 0.50829306 |
| 122 | CDK8 | 0.50700993 |
| 123 | PRKCQ | 0.50676303 |
| 124 | PIK3CG | 0.49867488 |
| 125 | MAP3K13 | 0.49587447 |
| 126 | SCYL2 | 0.49562155 |
| 127 | CDC42BPA | 0.48662744 |
| 128 | RPS6KA6 | 0.47948713 |
| 129 | TRIB3 | 0.47726109 |
| 130 | RPS6KL1 | 0.47558405 |
| 131 | RPS6KC1 | 0.47558405 |
| 132 | PAK2 | 0.47502721 |
| 133 | TYRO3 | 0.47185004 |
| 134 | PLK3 | 0.46571895 |
| 135 | MAP3K8 | 0.46248032 |
| 136 | NEK6 | 0.46208811 |
| 137 | MAP3K6 | 0.44049503 |
| 138 | WEE1 | 0.42875113 |
| 139 | IRAK1 | 0.42076632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33478449 |
| 2 | Measles_Homo sapiens_hsa05162 | 1.87481469 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84963633 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80561479 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79812284 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 1.71879833 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70706905 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66105193 |
| 9 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62226141 |
| 10 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.60319430 |
| 11 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.56813011 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55459832 |
| 13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.55366142 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50243451 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.49084916 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48563680 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45972265 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40121521 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39705567 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.38785553 |
| 21 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.37453605 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.36368429 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.35074236 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.34743287 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32827383 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.32321608 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.32077476 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31799103 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.30085274 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29495832 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.29347862 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26931996 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26816057 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.26371378 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24686083 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.22942297 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.22615702 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.19929534 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.18747376 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17450158 |
| 41 | Colorectal cancer_Homo sapiens_hsa05210 | 1.17274351 |
| 42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.17117552 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16278084 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.14243417 |
| 45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.11912201 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11109576 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09014792 |
| 48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.08484285 |
| 49 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.06483534 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05601262 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 1.05119577 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04238394 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 1.03962138 |
| 54 | Prostate cancer_Homo sapiens_hsa05215 | 1.03352027 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02539128 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02160657 |
| 57 | Homologous recombination_Homo sapiens_hsa03440 | 1.00890682 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.00342829 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00302408 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99956983 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99397411 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.98111890 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97894931 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.97360144 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 0.96340330 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91646193 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90647851 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88858519 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87897932 |
| 70 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.87773472 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86994759 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86773284 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86393826 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.85717293 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85249633 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.84878808 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83131313 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83056671 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80458725 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79250836 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78348198 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.77891622 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76706014 |
| 84 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.76583186 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75741359 |
| 86 | Pathways in cancer_Homo sapiens_hsa05200 | 0.74699409 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74350422 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74181323 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.73839907 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.73209596 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.72517105 |
| 92 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71565480 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70988328 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68680388 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68521359 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66775140 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66208767 |
| 98 | Melanoma_Homo sapiens_hsa05218 | 0.65957848 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65799848 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64920724 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64838172 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.64461104 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64165676 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.62763822 |
| 105 | Asthma_Homo sapiens_hsa05310 | 0.62393605 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61035092 |
| 107 | RNA transport_Homo sapiens_hsa03013 | 0.60710198 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59886769 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59812933 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.58982506 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57899039 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57233035 |
| 113 | Alcoholism_Homo sapiens_hsa05034 | 0.57063775 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56389734 |
| 115 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.55940783 |
| 116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55169781 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54605025 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53669666 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52424378 |

